Shimaa B Hemdan
Shimaa B Hemdan
Lecturer of biochemistry
Verified email at
Cited by
Cited by
Need’s assessment for faculty development at an Egyptian medical school: a triangulation approach
E Abdelkreem, SA Abo-Kresha, EA Ahmed, D Ibrahim, SB Hemdan, ...
International Journal of Community Medicine and Public Health 7 (5), 1669-1679, 2020
Liver Involvement in COVID-19 infected patients
MM Abd El Rhman, NS Shafik, A Maher, SB Hemdan, RM Abd Elhamid
Sohag Medical Journal 24 (2), 15-19, 2020
Molecular Docking and In-vitro Evaluation of Apoptotic Effect of Novel Synthetic Organocopper Derivative in Human Breast Cancer Cell line as Anticancer Agent
NM Darwish, AM Saleh, SB Hemdan, AAM Abdallah
Protective Effect of Hesperidin on Kidneys and Testes of Adult Male Rats Exposed to Bisphenol A
SE Kasem, AA Abdelnaby, PA Mohammed, SB Hemdan, A El-Fattah, ...
The Egyptian Journal of Hospital Medicine 88 (1), 3005-3013, 2022
Assessment of Serum Vitamin D and Total Calcium Levels in COVID- 19 Infected Patients and Their Relation to Disease Severity
MM Abdelrahman, SB Hemdan, AM Alkabeer, MA Haridy, MA Mahmoud, ...
Afro-Egyptian Journal of Infectious and Endemic Diseases, 2022
Decreased Serum zinc, selenium, and vitamin E as possible risk factors of hepatic fibrosis in non-alcoholic fatty liver disease
AAM Abdallah, MM Abdelrahman, HMAAS Attia, A Hafez, ...
Nutrition and Health, 02601060221103032, 2022
Non-small-cell lung cancer and survivin− 31G/C promoter polymorphism relation
AR Khalaf, AM Foad, SB Hemdan, EE Nabil, HM Esmaeel
The Egyptian Journal of Chest Diseases and Tuberculosis 70 (2), 236, 2021
Biochemical study of survivin-31G/C promoter polymorphism in breast Cancer
NS Ahmad, SEDA El-Noeman, A Morad, S Hemdan
Sohag Medical Journal 23 (2), 68-78, 2019
Survivin-31G/C promoter polymorphism and P53 antibodies in breast cancer
NS Ahmad, SED El-Noeman, S Hemdan
Sohag Medical Journal 23 (2), 71-76, 2019
The system can't perform the operation now. Try again later.
Articles 1–9